- Investing Ideas
- Belgian Pharmaceuticals & Biotech Leverage Leaders
Belgian Pharmaceuticals & Biotech Leverage Leaders
Results
3
0 new
3 companies
UCB
Market Cap: €45.1b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€237.10
7D
-8.6%
1Y
38.7%
Financière de Tubize
Market Cap: €9.3b
Financière de Tubize SA holds a stake in UCB, a biopharmaceutical company in Belgium.
TUB
€208.60
7D
-7.0%
1Y
53.4%
argenx
Market Cap: €47.8b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€763.80
7D
-8.1%
1Y
59.0%